Depletion of NRP1 in CD4+ T cells resulted in breakdown of tumor induced tolerance and activated antitumor immune response in tumor bearing mice, evident from increased CD8+ and reduced Treg cell infiltration into the TME, lesser tumor burden and improved tumor free survival. This evidence concerns the gene CD4 and neoplasm.